Jiu'an Intelligent and Kangrui New Materials' IPO review status on the Shenzhen Stock Exchange has changed to "terminated (withdrawn)."
On June 30th, Ji'an Intelligent and Kangrui New Materials' status for IPO review on the Shenzhen Stock Exchange changed to "terminated (withdrawn)".
On June 30th, Jiuan Intelligent and Kangrui New Materials' IPO review status on the Shenzhen Stock Exchange has changed to "terminated (withdrawn)."
Jiuan Intelligent is a manufacturer of intelligent visual products, an IoT operation service provider, and an IoT technology solution provider. With core technologies in visual imaging and analysis, wireless transmission, IoT platform, and AI visual application models, the company independently researches, produces, and sells intelligent hardware products. They also provide operation services using IoT cloud platforms to build an integrated model of "hardware + platform + service." After years of continuous development, the company has accumulated a certain market influence in the field of intelligent cameras.
Kangrui New Materials is a national-level specialized and high-tech enterprise focused on the research, production, and sales of high-precision, high-performance, and specific-structure precision metal materials. The company's precision metal materials products include metal laminated composite materials, precision metal profiles, precision metal polishing rods, fine metal wires, precision metal pipes, and various other product forms. These products cover a range of metal materials such as titanium-aluminum composites, titanium alloys, stainless steel, aluminum alloys, etc. The product range is diverse, with a primary focus on consumer electronics applications.
Related Articles
.png)
CSPC PHARMA (01093) has received a $25 million research and development milestone payment from AstraZeneca under a strategic collaboration and licensing agreement.

US Stock Market Move | Concept stocks related to optical communication generally fell, with Applied Optoelectronics (AAOI.US) dropping more than 6%.

GUMING (01364) spent HK$5.758 million to repurchase 288,000 shares on July 10th.
CSPC PHARMA (01093) has received a $25 million research and development milestone payment from AstraZeneca under a strategic collaboration and licensing agreement.
.png)
US Stock Market Move | Concept stocks related to optical communication generally fell, with Applied Optoelectronics (AAOI.US) dropping more than 6%.

GUMING (01364) spent HK$5.758 million to repurchase 288,000 shares on July 10th.

RECOMMEND





